Caricamento...
Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
Immunotherapy in lung cancer treatment is a long history paved with failures and some successes. During the last decade, the discovery of checkpoints inhibitors led to major advances in treating advanced and metastatic non-small cell lung cancer (NSCLC). Impressive data from early phase I-II studies...
Salvato in:
| Pubblicato in: | Front Med (Lausanne) |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105823/ https://ncbi.nlm.nih.gov/pubmed/32266275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00090 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|